![Brian Nichols](https://investorplace.com/wp-content/uploads/userphoto/17347.jpg?20240829a)
Recent Articles
Biotech Stocks That Could Double in 2016: Acadia Pharmaceuticals (ACAD)
By
Brian Nichols, InvestorPlace Contributor
ACAD stock may look expensive, but it's still going to double next year thanks to a new drug with a Breakout Therapy designation.
Wall Street Power Pairing: Alibaba, Disney Team Up (BABA, DIS)
By
Brian Nichols, InvestorPlace Contributor
BABA and DIS partner for content, but which is better for investors? Alibaba or Disney stock?
AAPL Stock: Apple’s Upgrade Program Is Soaring
By
Brian Nichols, InvestorPlace Contributor
Apple stock will gain as AAPL's successful iPhone Upgrade Program exceeds even bullish expectations.
Don’t Be Tricked Into Buying JNPR Stock; Pick Up CSCO Instead
By
Brian Nichols, InvestorPlace Contributor
Investors, be cautious -- JNPR is set up for future disappointment, while CSCO is positioned to thrive.
Why GigaPower Is Important for the Future of AT&T Stock
By
Brian Nichols, InvestorPlace Contributor
AT&T has aggressively upped the rollout of GigaPower nationwide, which could have big implications for T stock price long-term.
![Louis Navellier's Market 360 logo](https://investorplace.com/wp-content/uploads/2021/10/lnel-logo-new-175x25-1.png)
Join Louis Navellier’s Market 360 — FREE!
Get Louis Navellier’s take on the news and events impacting the market, plus his top stock picks.